This study will be conducted to study the effect of Desmopressin on the nocturnal micturition frequency in patients with idiopathic Parkinson syndrome.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
1
Desmotabs encapsulated, 0,2 mg once daily for one week, 0,2 mg bid for one week
Klinikum der Johannes Gutenberg-Universität Mainz, Studienzentrum Neurologie, Langenbeckstr. 1, 55131 Mainz
Mainz, Germany
average nocturnal micturition frequency within the 2 weeks treatment phase each
Time frame: 6 weeks
safety and efficacy on nocturnal micturition frequency of Desmopressin in patients with Parkinson syndrome
Time frame: 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.